Top Flatiron Horizon Alternatives

The Veradigm Real-World Evidence (RWE) analytics platform serves as a cost-effective software-as-a-service solution specifically crafted for the thorough and effective examination of real-world data. Organizations in the fields of life sciences and clinical research utilize this platform to explore electronic health records (EHR) data in depth. By conforming to OMOP standards, the analytical platform boosts both the reliability and efficiency of real-world evidence generation. Utilizing Veradigm Network data allows users to conduct population analyses within minutes, create reusable patient cohorts that maintain consistent terminology across diverse data sources, and carry out repeatable retrospective studies. Furthermore, the platform is capable of analyzing any dataset that adheres to the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM), which includes data drawn from Veradigm Network EHR. This robust tool not only streamlines the research workflow but also significantly improves the quality of insights gained from real-world data, thereby facilitating better decision-making in healthcare. Ultimately, the platform represents a crucial advancement in harnessing real-world evidence for impactful outcomes in the medical field.

Verana Health functions as a sophisticated platform for real-world data, transforming both structured and unstructured elements from electronic health records into curated, de-identified, disease-specific data modules via its clinician-informed and AI-augmented VeraQ population health data engine. By consolidating information through essential partnerships with leading medical registries, such as the American Academy of Ophthalmology, Neurology, and Urological Association, the platform combines insights from over 20,000 healthcare professionals and nearly 90 million patient records, thus offering high-quality datasets in near real-time for generating real-world evidence, pinpointing clinical trial sites and subjects, monitoring clinician performance, and maintaining medical registries. Users benefit from this extensive data repository through cloud services like AWS Data Exchange and Amazon Redshift, which feature self-service API access, an intuitive dashboard, and tools for personalized cohort exploration. Additionally, the system utilizes state-of-the-art AI and machine learning algorithms alongside thorough data quality evaluations to guarantee the dependability and precision of the information supplied. This pioneering method not only streamlines data application but also significantly improves the quality of healthcare research and practice, fostering an environment where informed decisions can be made with confidence. Ultimately, Verana Health exemplifies how technology can bridge the gap between clinical data and actionable insights, shaping the future of medical research.

The Aetion Evidence Platform® delivers critical real-world evidence tailored for stakeholders within the life sciences arena, such as pharmaceutical firms, payers, and healthcare providers who are managing financial risks. Our objective is to assist you in addressing key healthcare challenges: pinpointing the most effective treatments, recognizing suitable patient demographics, and determining the best timing for interventions. This methodology fosters improved decision-making, which in turn leads to better health outcomes. As a reliable partner to many top global biopharma organizations, significant payers, and the FDA, Aetion is instrumental in steering some of the most crucial decisions within the healthcare field. Our straightforward and transparent analyses drive progress in product development, market strategies, and payment reforms as the industry evolves to meet contemporary challenges. The Aetion Evidence Platform revolutionizes the application of real-world evidence, moving from simple descriptive analysis to establishing causal links, and delivering valuable insights in a matter of days or weeks—vital for enhancing both clinical effectiveness and financial performance. By harnessing your existing data, you can unlock actionable insights that propel immediate enhancements in your operations, paving the way for a more efficient healthcare system. This comprehensive approach not only supports individual organizations but also contributes to the overall advancement of healthcare practices.

ConcertAI emerges as a leading provider of AI-powered solutions in the healthcare industry, with a significant emphasis on oncology. The company's primary goal is to improve patient outcomes and accelerate insights by utilizing high-quality real-world data, innovative AI technologies, and profound scientific expertise. They offer a comprehensive range of products and services designed to enhance both clinical research and the experiences of patients. Their Real-World Data Products provide extensive and tailored datasets that meet a variety of research requirements for different organizations. By streamlining clinical trial processes, their digital trial solution boosts efficiency, while the Clinical Trial Optimization (CTO) platform harnesses advanced AI capabilities to enhance the design and execution of trials, particularly in oncology and hematology. Furthermore, in collaboration with NeoGenomics, ConcertAI has launched CTO-H, a software-as-a-service (SaaS) offering that focuses on hematological malignancies, delivering advanced research analytics and improving operational workflows. This combination of innovative technologies not only bolsters research capabilities but also plays a crucial role in advancing patient care within challenging medical specialties. Ultimately, ConcertAI's commitment to integrating AI into healthcare is reshaping the landscape of oncology and enhancing overall treatment pathways.

Atropos Health provides instant access to real-world data, effectively bridging the divides in healthcare and life sciences. Proven to improve clinical outcomes, speed up research initiatives, and boost operational efficiency, Atropos Health transforms medical data into actionable insights, compressing research timelines from months to just minutes. At the core of our services is a generative evidence acceleration operating system that facilitates the secure organization and installation of medical information for future use. Our advanced analytics capabilities allow for on-demand evidence generation and can easily integrate with your existing data systems after installation, or take advantage of our expansive global evidence network, which includes over 160 million patient records and a repository of 10,000 prior studies. By partnering with Atropos Health, prominent health systems and life science organizations can accelerate research, improve clinical trials, enhance decision-making in clinical settings, address discrepancies in care, and much more, ultimately reshaping the landscape of healthcare innovation. Join us in transforming the approach to harnessing evidence in medicine, fostering a future where data drives improved patient outcomes and healthcare practices.

Truveta functions as a health data and analytics platform aimed at utilizing information to improve patient experiences. By aggregating de-identified electronic health records from over 30 different healthcare systems, it offers researchers a comprehensive selection of patient data, encompassing clinical notes, imaging, and genomics. This extensive database encompasses information from more than 120 million patients, providing a well-rounded view of healthcare practices across the United States. The Truveta Studio acts as the analytics core of the platform, providing researchers with advanced tools such as notebooks and dashboards, all while ensuring compliance with HIPAA regulations. With its commitment to real-time data, the platform updates its information daily, ensuring that insights into patient care and health outcomes remain relevant and up-to-date. In addition, Truveta emphasizes the importance of data accuracy through its deployment of the Truveta Language Model, an innovative AI framework that adeptly converts EHR data into exact and dependable data points for medical research enhancement. This unwavering focus on data integrity not only boosts research capabilities but also cultivates a deeper comprehension of healthcare trends and the needs of patients, ultimately leading to better health results and improved care strategies. As a result, Truveta significantly contributes to the ongoing evolution of healthcare analytics and patient care improvement.

We explore health beyond conventional medical settings to better understand the impact of diseases on individuals. This comprehensive view of patient health uncovers new opportunities for business by introducing innovative ways to measure disease and overall wellness. By focusing on how illnesses influence everyday life, we can improve engagement with both healthcare providers and insurance payers, while also enhancing support for patients. Our goal is to create advanced algorithms that can predict the onset and progression of diseases, as well as identify key moments for timely interventions. Leveraging real digital data, we promote the benefits of our services. Our technology-enabled platform supports real-world research that incorporates unique behavioral data from daily life, offering advantages to clinical, medical affairs, and commercial sectors through Evidation's virtual research hub, Achievement. With customizable study designs and strategies for device integration, we streamline protocol management to ensure effective study execution. Moreover, we provide the option for sponsorship by either our team or your organization, fostering collaborative efforts tailored to specific needs. Ultimately, this approach aims to enhance the overall healthcare landscape by integrating innovative methodologies that benefit all involved stakeholders.

Regardless of the size of your clinic or its geographical position, MOSAIQ Plaza* provides you with vital digital resources to deliver outstanding multidisciplinary care for your patients, ensuring their journey from diagnosis to survivorship is marked by consistency, reliability, and security while also producing valuable real-world evidence. Elekta has rolled out comprehensive solution packages aimed at enhancing your team's capability to deliver care and refine treatment workflows, enabling you to focus on what truly matters: your patients. As we forge ahead into the future of multidisciplinary cancer care, MOSAIQ 3 sets new standards in oncology workflow and information management. By utilizing the seamless accessibility of the MOSAIQ Plaza environment, you will witness significant efficiencies and a more streamlined operational process, which ultimately boosts patient outcomes and satisfaction. This commitment to innovation not only transforms care delivery but also empowers healthcare professionals to excel in their roles.

At Enlitic, we are convinced that leveraging artificial intelligence can revolutionize the healthcare sector by enhancing data management and streamlining clinical processes. Our goal at Enlitic is to harness the capabilities of artificial intelligence to effectively manage healthcare data, thereby increasing capacity, optimizing clinical workflows, and establishing a robust real-world evidence medical image database for healthcare practitioners. With the help of our Enlitic Framework, we strive to transform healthcare intelligence, empowering professionals to make well-informed decisions and deliver tailored care to each individual patient, ultimately improving overall health outcomes.

Genoox is at the forefront of transforming the genomics sector through its vibrant and growing community, which fosters the creation of a comprehensive database and aids in providing actionable, real-world genomic insights that profoundly impact lives, improve clinical outcomes, and shape healthcare business strategies. By leveraging the collective strength of its community, Genoox effectively combines public data with user-generated content to streamline the process from DNA sample to clinical report, enhancing patient care by making genomic data more accessible and relevant at key moments. The company's pioneering solutions are reshaping the genomics landscape while also providing valuable support to research and life sciences organizations through a robust platform that utilizes real-world data and evidence, enhanced by in-depth genomic analytics that help researchers decode complex genomic information and achieve significant advancements using state-of-the-art genetic tools. In addition, Genoox partners with biosystems companies, including DNA sequencing firms, to integrate its sophisticated genomic engine with specialized assays, thereby improving the overall functionality of the genomics ecosystem. This collaborative approach not only amplifies the capabilities of genomic research but also reinforces Genoox's mission to empower healthcare practitioners and researchers in their quest for innovation. By constantly pushing the boundaries of genomic science, Genoox is dedicated to making a long-lasting impact in the field.

Tempus AI, a leading health tech company located in Chicago, Illinois, is focused on revolutionizing patient care through the integration of advanced artificial intelligence and precision medicine. By harnessing data and AI, the firm aims to develop customized treatment strategies spanning various medical fields, including oncology, cardiology, radiology, and mental health. Their comprehensive platform merges genomic sequencing, clinical data, and AI-driven analytics, thereby providing healthcare professionals and researchers with vital insights. Tempus enhances patient understanding through a variety of testing methodologies, such as tissue and liquid biopsies, DNA and RNA sequencing, somatic and germline testing, as well as tumor-normal matched profiling and minimal residual disease monitoring. In addition, the company presents a fast and reliable platform for test ordering, acquiring patient insights, and integrating AI technologies into medical practice. Their innovative generative AI-enabled clinical assistant further streamlines access to patient insights, improving the efficiency of healthcare delivery. This dedication to leveraging state-of-the-art technology underscores Tempus AI's mission to elevate health outcomes and propel advancements in medical research. Ultimately, Tempus AI strives to be at the forefront of a transformative era in healthcare.

Jeeva has developed a revolutionary modular system that operates on a cutting-edge cloud platform. With just one login from any device that supports a browser, users can easily screen patients, offer education, manage enrollment, send SMS and emails, and compile evidence such as electronic patient-reported outcomes. Frustrations with slow patient recruitment and retention are common in the industry, making it imperative to gather solid evidence of safety and efficacy for new investigational medicines to secure approval from regulatory agencies. Jeeva stands out as an invaluable resource for optimizing time and financial resources for patients and biopharma sponsors, particularly in long-term follow-up studies associated with gene therapy. Its innovative approach streamlines processes, ultimately enhancing the efficiency of clinical trials and improving patient care.

The ARIA® oncology information system is tailored to support both medical and radiation oncology, including proton therapy, ensuring a broad spectrum of functionalities. It facilitates the review and management of clinical images, prescriptions, lab results, quality assurance data, and patient outcomes, among other important information. Cancer staging is automatically aligned with AJCC guidelines, and the system offers flexible management options for toxicities. With a strong focus on interoperability, ARIA enables seamless use of patient data across a variety of devices and platforms. It provides robust support for HL7 and DICOM standards, which simplifies the transfer of patient information between different healthcare facilities. By granting immediate access to patient data, the system empowers healthcare teams to improve their planning capabilities and make real-time adjustments. Additionally, ARIA enhances the effectiveness of image-guided treatment techniques by efficiently utilizing radiographic, fluoroscopic, and cone-beam CT images. The system also keeps track of essential activities for evidence-based Pay-for-Performance programs, all while maintaining compliance with HIPAA regulations. Moreover, ARIA systematically organizes and stores patient data and images, ensuring that healthcare teams remain well-informed and focused on delivering optimal care. This all-encompassing approach not only streamlines workflows but also plays a significant role in improving patient outcomes, ultimately leading to a more effective oncology care experience.

The costs, complexities, and extended durations associated with conventional evidence generation methods restrict the nimbleness of research, making it challenging to fully integrate authentic patient perspectives into the development and commercialization of treatments. Our HyperStream operates as the world's most extensive real-time repository of patient experience data, capturing the true digital stories of illnesses as shared by actual patients across diverse online platforms. The Pharos platform serves as a web-based tool designed for evidence generation and a research framework that harnesses its integrated data streaming and artificial intelligence capabilities to efficiently collect online patient experience data, enabling teams to rapidly identify critical evidence when needed. To date, the Pharos Suite has successfully produced significant evidence and patient insights in numerous therapeutic areas and medical conditions, showcasing its adaptability and influence on research methodologies. This groundbreaking strategy not only accelerates the evidence collection process but also deepens the comprehension of patient experiences as they unfold in real-time, reinforcing the value of patient narratives in shaping future healthcare solutions. Ultimately, by bridging the gap between research and patient input, we can foster a more responsive and effective healthcare ecosystem.

Enhance the quality of your patient interactions by reducing the time spent on electronic health records through the efficient workflows provided by OncoEMR®. This innovative platform is specifically designed for oncology practices, equipped with unique tools like Document Search that can significantly reduce task completion time from several minutes to just seconds. As MIPS evolves, OncoEMR® offers vital resources to help navigate the program effectively, facilitating the collection and reporting of necessary data while supporting workflows and compliance with reporting requirements. Tailored for community oncology settings, OncoEMR® includes features such as NCCN Chemotherapy Order Templates® and up-to-date AJCC disease factors, making it an indispensable resource for diagnostics and treatment planning. Before you start using OncoEMR®, Flatiron will ensure that your current EHR database is migrated smoothly, guaranteeing that you can hit the ground running on your first day. Once the migration is complete, you'll have access to more than 150 preloaded reports, allowing you to gather critical insights into your clinical metrics and operational performance, including patient wait times. This comprehensive set of tools not only boosts operational efficiency but also significantly enhances patient care and outcomes within your oncology practice, ultimately leading to a more effective healthcare environment. With OncoEMR®, the focus remains firmly on the patient, ensuring that care remains a top priority.

TriNetX serves as a global health research network that connects healthcare organizations with life sciences companies to improve real-world research and accelerate the development of cutting-edge therapies. Through a self-service platform compliant with HIPAA, GDPR, and LGPD, TriNetX provides users access to federated electronic health records, diverse datasets, and consulting partnerships. This functionality enables the international research community to refine protocol design, streamline trial operations, enhance safety signal evaluations, and increase the production of real-world evidence. The network features an extensive dataset encompassing over 275 million patients from 150 healthcare entities across 25 countries, offering a valuable resource for research initiatives. Researchers utilizing the TriNetX platform have explored more than 26,000 protocols and presented over 7,000 clinical trial opportunities to healthcare professionals, significantly reducing site identification time for clinical trials by an impressive 50%. By fostering collaboration among various stakeholders, TriNetX not only stimulates progress in medical research but also plays a crucial role in improving patient care on a global scale. Moreover, the ability to easily navigate and leverage comprehensive data enhances the potential for groundbreaking discoveries that can transform the healthcare landscape.

Clinithink distinguishes itself as a leading technology company within the healthcare industry, specializing in artificial intelligence innovations that transform unstructured medical data into meaningful insights. Their proprietary platform, CLiX, utilizes Clinical Natural Language Processing (CNLP) to interpret complex clinical narratives, which in turn enables healthcare providers to enhance patient outcomes and boost operational efficiency. Clinithink offers tailored solutions across diverse sectors such as life sciences, revenue cycle management, and population health, effectively addressing challenges like patient cohort identification, reimbursement optimization, and disease progression tracking. With its state-of-the-art technology, Clinithink has garnered trust from major pharmaceutical and healthcare organizations worldwide, solidifying its position as a frontrunner in healthcare AI and digital health advancements. Additionally, the CLiX platform excels at recognizing a broad spectrum of complex clinical concepts, including certainty, severity, laterality, and temporality, which significantly improves its effectiveness in various clinical environments. As the healthcare landscape continues to evolve, Clinithink is dedicated to refining its technology to adapt to the shifting requirements of the industry, ensuring it remains at the forefront of innovation. This commitment to continuous improvement positions Clinithink as a critical partner in the quest for better healthcare solutions.

Suvoda stands as a prominent player in the arena of clinical trial technology, concentrating on complex, life-saving research in areas such as oncology, central nervous system disorders, and rare diseases. Founded in 2013, the organization offers a robust platform equipped with Interactive Response Technology (IRT), electronic Consent (eConsent), electronic Clinical Outcome Assessments (eCOA), and ePatient solutions, all designed to optimize critical patient engagements. Their cutting-edge software ensures a seamless user experience, facilitating precise randomization, effective drug supply management, and prompt data gathering. Committed to enhancing patient comprehension and reducing the burdens faced by trial sites, Suvoda's solutions are crafted to adapt to the growing intricacies of clinical research. Headquartered near Philadelphia, with additional branches throughout Europe and Asia, Suvoda has proudly aided in the execution of over 1,500 trials across more than 85 countries, demonstrating their extensive global influence and proficiency in the industry. Their unwavering focus on innovation and high standards establishes them as an essential ally in the progress of clinical research, paving the way for future breakthroughs and transformations in the field.

Unlock the full potential of your data to elevate the experiences of both your clinic and your patients. InSightive transforms your oncology information into actionable insights that can be implemented without delay. By standardizing and organizing your data through oncology-specific connections, you can achieve improved clarity and accuracy. Utilizing top-tier Tableau visualization, our platform provides analytics customized for the oncology sector, significantly enhancing clinical performance. You can access InSightive through ARIA, a dedicated desktop application, or virtually any web browser, offering flexibility in how you engage with your data. Begin your journey with customizable templates that focus on payer mix, referral sources, and operational efficiency to streamline your processes. Quickly combine activity data to reveal invaluable operational insights, allowing you to explore your information in innovative and relevant ways. Experience fast query results that enable treatment or policy modifications within hours instead of days, empowering your patients to benefit from the collective knowledge of previous cases. Furthermore, our data specialists are on hand to help you effortlessly integrate Varian into your current workflow, ensuring you fully harness the potential of your oncology data for better patient outcomes. With InSightive, you have the future of oncology data management right at your fingertips, ready to drive significant improvements in patient care. Embrace this opportunity to transform your clinic's operations and enhance the overall patient experience.

Transform your scattered health information into a cohesive and accessible format with an interactive AI and NLP platform that delivers critical health insights for a diverse range of stakeholders. This cutting-edge technology benefits Providers by expediting the data abstraction process and validating clinical information within notes, which in turn reduces the time and expenses linked to pinpointing care gaps, evaluating care quality through dashboards, and generating registry reports. For Payers, it enhances the integration and analysis of claims data alongside clinical notes, thereby improving the management of high-risk and high-cost member populations. In the Life Sciences sector, this solution accelerates patient matching for clinical trials by utilizing both databases and clinical note data, effectively tapping into the potential of real-world clinical evidence. Ember seamlessly combines NLP with predictive analytics, optimizing healthcare analytics for unstructured data to enhance quality, efficiency, and outcomes throughout the healthcare system. Consequently, stakeholders are empowered to make well-informed decisions that not only elevate patient care but also optimize resource allocation for better healthcare delivery. Ultimately, this holistic approach fosters a more connected and efficient healthcare ecosystem.

Boost the effectiveness and efficiency of cancer treatment across diverse healthcare settings. Created in close collaboration with oncology professionals, iKnowMedSM functions as an electronic health record (EHR) that provides crucial patient data exactly when needed and is accessible from almost any device. With cutting-edge user interface design and an exceptional mobile platform, iKnowMed EHR offers comprehensive point-of-care treatment decision support along with customizable features that integrate smoothly into existing workflows. Equip your patients with extensive clinical support by leveraging a continuously updated database of oncology treatment protocols, drug availability, and clinical outcomes. Access to evidence-based clinical guidelines and pathways is ensured at the moment it is necessary, facilitating timely and effective decision-making. Additionally, keep treatment alternatives up-to-date by incorporating information on treatment costs, insurance coverage, and reimbursement details, thus aiding both patients and healthcare providers in navigating the intricate landscape of cancer care. By adopting these practices, healthcare providers can not only enhance patient outcomes but also streamline the entire treatment process, ultimately leading to a more effective cancer care system. As a result, this comprehensive approach promotes better health for patients and greater efficiency for providers.

REDCap Cloud functions as an all-encompassing data science platform that enables organizations to collect, combine, standardize, analyze, and share clinical and research data that adheres to both real-world and regulatory standards, all within a unified, standards-focused framework. This platform supports the entire lifecycle of randomized clinical trials and real-world evidence research by offering a variety of modules designed for complex trial design and implementation, a centralized hub for clinical data that merges eCRF and non-eCRF sources, and AI/ML functionalities that provide real-time operational and data insights, along with smooth integration with eSource and EHR systems. Furthermore, it boosts patient engagement through features such as ePRO/eCOA and wearable technologies, catering to both hybrid and decentralized trial formats. Its analytics capabilities include provisions for synthetic control arms and digital twins, ensuring compliance with global security regulations. Ultimately, REDCap Cloud aims to break down data silos, reduce vendor fragmentation, enable bidirectional data exchanges, and provide sponsors, CROs, and health systems with thorough visibility and oversight of site performance, study data integrity, and regulatory readiness. By optimizing these processes, organizations can significantly enhance the efficiency and effectiveness of their research initiatives, leading to improved outcomes and insights.

inSight provides a comprehensive range of applications designed to deliver researchers accurate and timely information. The process of wound assessment and documentation is improved through the use of single image capture, which is securely synced in a setting that adheres to HIPAA, GDPR, and 21 CFR Part 11 regulations. This platform strives to create a seamless integrated research experience. By leveraging new data and clinical evidence, researchers can effectively develop study protocols, imaging charters, and adjudication manuals. The system facilitates easy construction and customization of databases, while also allowing for the tailoring of clinical workflows that integrate effortlessly with your EDC. A dedicated project manager is appointed to ensure that the project kicks off on time and remains well-maintained throughout its duration. Enhance the reliability of your clinical study by following the highest quality standards and employing strong quality assurance and control measures. Users can perform real-time data analysis and extract insights, which aids in the curation of data sets and bolsters clinical studies with real-world evidence. Additionally, our advanced wound imaging solution is CE-marked and registered with the FDA, having gone through clinical validation to confirm its efficacy and compliance. With such stringent standards in place, inSight distinguishes itself as a reliable partner in clinical research. The commitment to upholding these standards not only fosters trust but also encourages innovation in the field.

Cytel is recognized as a leading global innovator in the realm of software dedicated to clinical trial design, biometrics, and sophisticated analytics, with a goal of enhancing clinical trial efficiency while empowering pharmaceutical firms to fully leverage both clinical and real-world data. Founded in 1987 by esteemed statisticians Cyrus Mehta and Nitin Patel, Cytel has maintained its position at the forefront of adaptive clinical trial technology and biostatistics. Its flagship software, the East Horizon platform, plays a crucial role in supporting accurate trial design and simulation, utilizing adaptive and Bayesian approaches to refine protocols and streamline the drug development journey. The East Horizon platform represents a holistic integration of Cytel's trusted software solutions, boasting R integration that markedly enhances trial design capabilities. Additionally, Cytel offers the Xact software suite, an extensive toolkit tailored for statistical analysis of smaller datasets, effectively addressing challenges posed by sparse and missing data. By persistently innovating and broadening its range of products, Cytel is dedicated to delivering state-of-the-art solutions that align with the dynamic demands of clinical research, ensuring that researchers have the tools necessary to improve patient outcomes. As a result, Cytel continues to shape the future of clinical trials through its unwavering commitment to excellence in software development and analytics.

Deeplink Medical has focused its services around the MIRIO platform, which is tailored to meet the diverse needs and scenarios of those involved in medical imaging within the oncology field, applicable in both clinical environments and everyday practice. Our offerings include three distinct yet interrelated solutions: MIRIO, which monitors evaluations of solid tumors and tracks therapeutic responses in oncology patients; a streamlined patient pathway that connects hospital facilities with private medical practices; and an Imaging CRO that specializes in managing imaging data for oncological clinical trials. The creation of our cutting-edge solutions is supported by a scientific board, providing a solid foundation for our offerings. Furthermore, our collaborative workflow platform organizes imaging data and radiological assessments for patients with solid tumors, ensuring real-time data structuring in line with RECIST 1.1 and iRECIST guidelines from the point of data generation at investigation sites. This capability allows for immediate assessments of treatment responses based on recognized international standards, significantly improving the quality and efficiency of oncological patient care. By integrating these services, we strive to deliver a holistic approach that empowers healthcare professionals to achieve the best possible treatment outcomes while keeping pace with the evolving landscape of oncology. This commitment underscores our dedication to advancing patient care in this critical field.

DoseMeRx is recognized as the world’s first and largest Bayesian dosing platform, specifically designed for clinical applications. Our advanced platform expedites your path to achieving clinical goals while significantly improving patient outcomes and minimizing costs. Distinctively, we are the only Bayesian dosing solution in the world that possesses HITRUST certification, ensuring that patient data is safeguarded with the highest standards of protection and integrity. Benefit from uninterrupted continuity of care across your healthcare system through a few straightforward steps. You can effortlessly standardize your workflows and optimize your therapeutic drug monitoring strategies. Our extensive range of drug models covers various therapeutic areas, including vancomycin and infectious diseases, transplant medicine, cardiovascular and coagulation care, as well as oncology and pediatrics, providing comprehensive support for numerous clinical situations. This adaptability not only enhances the quality of care but also enables healthcare professionals to offer personalized treatment options with greater efficiency. Ultimately, DoseMeRx empowers providers to meet the unique needs of their patients, fostering improved health outcomes across diverse populations.

Pharmaceutical firms need a wealth of genomic information to successfully execute precision medicine strategies; however, they often utilize only a fraction—around 10%—of the total data at their disposal for decision-making. Genomenon offers an extensive database to counter this limitation. Their Prodigy™ Patient Landscapes deliver a cost-effective and efficient approach for conducting natural history research, which is crucial for developing treatments for rare conditions by expanding the understanding of both past and future health data. Employing a sophisticated AI-driven process, Genomenon meticulously analyzes each patient referenced in the medical literature much faster than traditional methods. It is essential to capture all pertinent insights by examining every genomic biomarker highlighted in scholarly articles. Each scientific assertion is backed by solid evidence sourced from medical literature, enabling researchers to identify all genetic factors and pinpoint variants classified as pathogenic according to ACMG clinical criteria, thus streamlining the creation of targeted therapies. By adopting this thorough strategy, pharmaceutical companies can significantly boost their research efficiency and, in turn, enhance patient outcomes. This innovative model not only fosters advancements in drug development but also contributes to a deeper understanding of genetic influences on health.

Mosaiq acts as a comprehensive oncology information system and electronic medical record platform that manages all facets of cancer care, from initial diagnosis and treatment planning to execution, monitoring, and reporting on outcomes. This platform unifies clinical, operational, and financial data into a single, integrated database, allowing healthcare providers access to complete patient records and fostering collaboration among various specialties such as radiation oncology and medical oncology. Additionally, it streamlines vital workflows including chemotherapy order management, planning and administering radiation therapy, scheduling appointments, billing, and clinical documentation. Users are also provided with decision support tools and customizable workflows, which help optimize routine tasks and improve accuracy in care. By incorporating these features, Mosaiq not only enhances the overall efficiency of cancer care delivery but also ensures that healthcare professionals can provide more coordinated and effective treatment plans for their patients. Ultimately, this leads to improved outcomes and a more patient-centered approach in oncology.

Mahalo Health is a comprehensive digital health platform designed to accelerate the development of patient-centered digital health solutions and clinical trials. It offers an array of prebuilt modules that enable the rapid deployment of customizable white-label applications tailored to specific therapeutic areas. The platform is equipped with advanced data capabilities, which include a predictive health engine for anticipating diseases and diagnoses, a behavior modification engine that promotes healthy patient habits, and a notification system that guarantees prompt communication via push notifications, SMS, or emails. Mahalo Health is dedicated to upholding rigorous security and compliance standards, adhering to regulations like HIPAA, GCP, ISO27001, and GDPR. Its diverse service offerings span various therapeutic domains, such as diabetes management, cognitive health, cardiovascular care, musculoskeletal issues, mental well-being, oncology, rare diseases, and nonalcoholic steatohepatitis (NASH). Furthermore, Mahalo Health not only enhances patient engagement but also improves health outcomes by equipping healthcare providers with innovative digital tools and solutions that adapt to the evolving needs of their patients. This commitment to innovation ensures that healthcare delivery is both efficient and personalized.

At ArborMetrix, we strive to improve healthcare by leveraging the capabilities of data science, and we are committed to delivering impactful and user-friendly technology alongside analytics. Our top-tier healthcare analytics offerings have demonstrated their ability to provide targeted, clinically relevant insights that not only improve clinical outcomes but also enhance financial performance, increase stakeholder value, and evaluate the real-world effectiveness of a range of treatments, procedures, medical devices, and pharmaceuticals. Patient registries serve a vital function across various medical fields, with post-market surveillance being among their most prominent uses. In order to help you create a dependable data resource, we implement a methodical strategy. It is crucial to ensure a streamlined and secure process for collecting large volumes of real-world data and preparing it for in-depth analysis. By utilizing the right technology, you can efficiently acquire data from a variety of sources, including medical records, regulatory information, patient-reported outcomes, and other resources that support post-market surveillance efforts. This extensive data collection not only supports compliance but also nurtures innovation in the realms of treatment and patient care, ultimately contributing to a more effective healthcare system. Furthermore, our commitment to excellence drives us to continuously refine our methodologies, ensuring that we meet the evolving needs of healthcare providers and stakeholders alike.